Technical analysis of Medpace Holdings, Inc. (MEDP): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance.
Price Performance
| 1 month | +8.76% |
| 3 months | +13.38% |
| Year-to-date | +16.09% |
| 1 year | +11.47% |
| 3 years | +137.78% |
| 5 years | +190.76% |
| 10 years | +2005.30% |
52-Week Range
| 52-week High | $693.70 |
| 52-week Low | $373.00 |
| Avg Volume (90d) | 294K |
Technical Indicators
| SMA 50 | $619.12 |
| SMA 200 | $529.37 |
| Beta | 1.39 |
| 30-day Volatility (annualised) | 33.9% |
| Price vs SMA 50 | +5.3% |
| Price vs SMA 200 | +23.2% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $561.65 | |
| 2026-01 | $582.48 | +3.7% |
| 2026-02 | $451.76 | -22.4% |
| 2026-03 | $480.19 | +6.3% |
| 2026-04 | $418.66 | -12.8% |
| 2026-05 | $447.11 | +6.8% |
| 2026-06 | $529.59 | +18.4% |
| 2026-07 | $577.11 | +9.0% |
| 2026-08 | $593.99 | +2.9% |
| 2026-09 | $624.18 | +5.1% |
| 2026-10 | $652.01 | +4.5% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2027-02-08 | $4.82 | $718M |
| 2026-10-21 | $4.44 | $714M |
| 2026-07-22 | $3.98 | $690M |
| 2026-04-22 | $3.92 | $698M |
| 2026-02-09 | $4.19 | $689M |
| 2025-10-22 | $3.53 | $641M |
| 2025-07-21 | $2.98 | $539M |
Price
| Price | $652.01 (closing price, October 30, 2026) |
| Market Cap | $18.2B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 36.14 |
| Price / Book | 31.14 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.25 |
| Current Ratio | 0.83 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 8.04 |